SCHEMBL19167697

SCHEMBL19167697

CCN1Cc2[nH]c3ccccc3c2C(=O)N(C)C1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.43
ROCK2 O75116 1/20 0.41
KDM4E B2RXH2 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
ALDH1A1 P00352 2/20 0.41
NPC1 O15118 1/20 0.41
HPGD P15428 1/20 0.41
TSHR P16473 1/20 0.41
RAB9A P51151 1/20 0.41
HSD17B10 Q99714 1/20 0.41
ADORA3 P0DMS8 1/20 0.40
ADORA2A P29274 1/20 0.40
ADORA2B P29275 1/20 0.40
ADORA1 P30542 1/20 0.40
NPEPPS P55786 1/20 0.39
CHRNA7 P36544 1/20 0.39
HTR1A P08908 1/20 0.38
CA12 O43570 1/20 0.37
RNASEH1 O60930 1/20 0.37
ERCC1 P07992 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19167988 0.87 ALDH1A1 (0.42) CYP1A2ROCK2KDM4ESMN1; SMN2ALDH1A1
SCHEMBL19169041 0.83 CHEK1 (0.38) ROCK2MEN1KMT2A
SCHEMBL19167816 0.81 ALDH1A1 (0.41) CYP1A2ROCK2KDM4ESMN1; SMN2ALDH1A1
SCHEMBL19168811 0.81 KDR (0.46) CYP1A2KDM4ESMN1; SMN2ALDH1A1HPGD
SCHEMBL22487791 0.80 MAOB (0.52) KDM4EHPGDHSD17B10MAPTHTT
SCHEMBL19169043 0.73 CA12 (0.39) CA12ERCC1FEN1CA9ERCC4
SCHEMBL6997570 0.69 SIRT2 (0.49) CYP1A2ROCK2KDM4ESMN1; SMN2ALDH1A1
SCHEMBL4738583 0.67 KMT2A (0.49) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL6362036 0.64 F2 (0.33)
SCHEMBL6366523 0.63 HSD17B3 (0.43) KDM4EALDH1A1NPC1HPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170210743-A1 NOVEL HDAC6 INHIBITORS AND THEIR USES Universitätsklinikum Jena (DE) 2017-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170210743-A1 NOVEL HDAC6 INHIBITORS AND THEIR USES HDAC6, HDAC5, HDAC4 CYP1A2 4605/4885ROCK2 761/4885KDM4E 676/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.